BR Biopharma, Inc. (BRBI) To Go Ex-Dividend on May 19th

BR Biopharma, Inc. (NASDAQ:BRBI) declared a quarterly dividend on Friday, May 8th. Investors of record on Tuesday, May 19th will be given a dividend of 0.147 per share on Friday, June 5th. This represents a c) annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Tuesday, May 19th.

BR Biopharma Stock Performance

BRBI stock opened at $14.41 on Friday. The company has a 50-day simple moving average of $14.80. BR Biopharma has a 52 week low of $12.15 and a 52 week high of $67.01.

BR Biopharma (NASDAQ:BRBI) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $25.95 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings began coverage on shares of BR Biopharma in a research note on Friday, February 13th. They set a “sell (e-)” rating on the stock. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

BR Biopharma Company Profile

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.